Results 11 to 20 of about 182,488 (255)
Journal of Global Antimicrobial Resistance, 2022 : Objectives: Staphylococcus argenteus is generally more susceptible to antibiotic treatments than Staphylococcus aureus; however, the study showed that the daptomycin/vancomycin-resistant S.
Chih-Hsiang Chang +9 more
doaj +2 more sources
Design and synthesis of modified peptide antibiotics of the vancomycin family [PDF]
, 2008 The ability of bacteria to constantly evolve new methods of resistance to antibacterial therapies represents a constant challenge in medicine. Emergence of strains of enterococci and S. Aureus that show resistance to vancomycin is an alarming phenomenon,
Bone, Philip Andrew
core +8 more sources
Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran
Drug, Healthcare and Patient Safety, 2018 Afsaneh Vazin, Motahare Mahi Birjand, Masoud Darake Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran Background: Vancomycin resistance in intensive care units (ICUs) accounts for ...
Vazin A, Mahi Birjand M, Darake M
doaj +1 more source
Pharmaceutics, 2023 Vancomycin is the front-line defense and drug of choice for the most serious and life-threatening methicillin-resistant Staphylococcus aureus (MRSA) infections.
El Tahra M. Ahmed +4 more
doaj +1 more source
Do Dose-Dependent Microbial Changes Occur during Spine Surgery as a Result of Applying Intrawound Vancomycin Powder?: A Systematic Literature Review [PDF]
Asian Spine Journal, 2018 We analyzed dose-dependent effects of vancomycin on wound infection bacteria and investigated the relationship between dose and microbial imbalances in patients treated with intrawound vancomycin powder during spine surgery.
Lunli Xie +4 more
doaj +1 more source
A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
Southern African Journal of Infectious Diseases, 2023 Background:Â Antimicrobial stewardship principles guide the clinical use of antimicrobials, including vancomycin, but paediatric vancomycin prescribing practices have not been evaluated in South Africa.
Leonore Greybe +5 more
doaj +1 more source
The Association of the mazEF Toxin-antitoxin System and Vancomycin Resistance in Clinical Isolates of Vancomycin Resistant Enterococcus faecalis [PDF]
, 2022 Vancomycin resistant enterococci are challenging bacteria as they are difficult to be eradicated. Toxin-antitoxin (TA) systems are genetic elements located in most prokaryotic genomes.
Nawal S. Gouda, Amira M. Sultan
core +1 more source
Microbiology Research, 2011 The decreased vancomycin susceptibility and subsequent emergence of vancomycin resistant Staphylococcus aureus (VRSA) strains already multi-resistant to antibiotics is a major public health problem.
Samuel Sunday Taiwo +4 more
doaj +1 more source
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection [PDF]
, 2014 OBJECTIVES: Fidaxomicin was non-inferior to vancomycin with respect to clinical cure rates in the treatment of Clostridium difficile infections (CDIs) in two Phase III trials, but was associated with significantly fewer recurrences than vancomycin.
Cornely, Oliver A. +5 more
core +1 more source
Cancer Control, 2021 Objectives Vancomycin-resistant enterococcus infections impact mortality in oncology patients. Given the low rate of vancomycin-resistant enterococcus bacteremia, low virulence of vancomycin-resistant enterococcus, and advent of rapid diagnostic systems,
Matthew Snyder PharmD +2 more
doaj +1 more source